vimarsana.com

காட்டொ பூர்வீகம் அமெரிக்கன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jobs paying nearly $120,000 coming to Durham County in biotech expansion

RALEIGH – Taysha Gene Therapies will add more than 200 jobs paying an average of some $120,000 as part of an expansion in Durham County. The company chose the Triangle over Dallas, Texas, for a 160,000 square foot facility which will serve as its manufacturing site. It is based in Dallas. It will invest $75 million as part of the expansion. Taysha joins a growing number of companies in the Triangle area focused on gene therapies. North Carolina’s Economic Investment Committee approved a state benefits package of more than $5 million for the project at a meeting Thursday morning. “North Carolina has a thriving life sciences ecosystem with significant expertise in gene therapy manufacturing, and we are delighted to establish our manufacturing center in Durham,” said RA Session II, founder and CEO of Taysha, in a statement. “With our management team with technical and manufacturing know-how leading the charge, this leading facility will serve as a center of excellence fo

Landing of $75M expansion of Texas-based Taysha adds to Triangle s growing gene therapy hub

by Jim Shamp, NCBiotech writer December 17, 2020 . RESEARCH TRIANGLE PARK – Dallas-based Taysha Gene Therapies announced plans today to invest $75 million in a gene therapy manufacturing facility in Durham that will employ more than 200 people. Taysha is joining the fast-growing community of cutting-edge gene- and cell-therapy companies setting up shop in the Research Triangle, where decades of investment and workforce training have created a magnet for the discovery and manufacture of science’s game-changers in fighting some of humankind’s most fearsome maladies. Taysha logo The company is developing gene therapies that use benign adeno-associated viruses (AAV) as “vectors,” or carriers, to transport genetic corrections to otherwise defective areas of the body. Taysha is initially targeting genetic diseases of the central nervous system, such as CLN1 disease, also called infantile Batten disease, which causes developmental delays in children, and Rett syndrome, a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.